Results 41 to 50 of about 12,403 (234)
Cardiogenetics, 2022 Eosinophilic pancarditis (EP) is a rare, often unrecognized condition caused by endomyocardial infiltration of eosinophil granulocytes (referred as eosinophilic myocarditis, EM) associated with pericardial involvement.
Michele Lioncino +19 more
doaj +1 more source
Journal of Allergy and Clinical Immunology, 2023 Hypereosinophilic syndrome (HES) and eosinophilic granulomatosis with polyangiitis (EGPA) are rare systemic inflammatory disorders with overlapping symptoms, elevated eosinophil counts, and heterogenous clinical presentations.
M. Wechsler +6 more
semanticscholar +1 more source
Medial medullary infarction caused by antineutrophil cytoplasmic antibody-related vasculitis: Case report and review of the literature [PDF]
, 2017 Rationale: Medial medullary infarction accounts for less than 1% of brain infarctions, and medial medullary infarctions is very rarely caused by antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis.Patient concerns: We report the case of a 76-
Ishii Kazuhiro +7 more
core +2 more sources
Frontiers in Immunology, 2023 Background Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare vasculitis characterized by asthma, systemic manifestations, and blood and tissue eosinophilia.
S. Nolasco +18 more
semanticscholar +1 more source
Incidence of ANCA-associated vasculitis in a UK mixed ethnicity population [PDF]
, 2016 Objectives: We aimed to estimate the incidence of ANCA-associated vasculitis in the UK and how this varied by ethnic group. Methods: We identified incident cases of ANCA-associated vasculitis between March 2007 and June 2013 in the Nottingham–Derby ...
Alfred Mahr +10 more
core +1 more source
Renal Involvement in Eosinophilic Granulomatosis With Polyangiitis [PDF]
Kidney International Reports, 2021 Eosinophilic granulomatosis with polyangiitis (EGPA), previously called Churg-Strauss syndrome, is a small to medium-sized systemic necrotizing vasculitis characterized by eosinophil-rich tissue infiltrates and granulomatous lesions. EGPA belongs to the larger subgroup of ANCA-associated vasculitides (AAV).
Doreille, Alice +5 more
openaire +3 more sources
BMC Pulmonary Medicine, 2023 Background Eosinophilic granulomatosis with polyangiitis (EGPA) is a form of anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis characterized by eosinophil-rich granulomatous inflammation and small-to-medium vessel vasculitis associated ...
I. Suzaki +6 more
semanticscholar +1 more source
Pakistan Armed Forces Medical Journal, 2021 Objective: To determine the clinical and laboratory features during the disease course in patients of anti cytoplasmic antibody (ANCA) associated vasculitis in Pakistani patients presenting to a tertiary care center.
Muhammad Zeeshan Aslam +3 more
doaj +3 more sources
International guidelines for the management ofANCA-associated systemic vasculitides
Современная ревматология, 2019 The paper deals with international guidelines for the management of antineutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitides (SVs) that are a group of severe life-threatening immune-mediated diseases. This group includes granulomatosis
T. V. Beketova
doaj +1 more source
Arthritis & Rheumatology, 2021 Mepolizumab proved to be an efficacious treatment for eosinophilic granulomatosis with polyangiitis (EGPA) at a dose of 300 mg every 4 weeks in the randomized, controlled MIRRA trial.
A. Bettiol +54 more
semanticscholar +1 more source